Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression

被引:2
|
作者
Yu, Jia [1 ]
Xu, Feng-Quan [2 ,3 ]
机构
[1] Beijing Changping Hosp Tradit & Western Med, Psychiat Dept, Beijing 102206, Peoples R China
[2] Chinese Acad Tradit Chinese Med, Guanganmen Hosp, Dept Psychosomat Med, Beijing 100053, Peoples R China
[3] Chinese Acad Tradit Chinese Med, Guanganmen Hosp, Dept Psychosomat Med, 5 Beixiange, Beijing 100053, Peoples R China
关键词
Jiajian Guipi decoction; Escitalopram oxalate tablets; Depressive disorder; Sleep quality; Traditional Chinese medicine syndromes; PREVALENCE; DISORDERS; THERAPY;
D O I
10.12998/wjcc.v11.i29.7017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDDepression is a widespread mental health condition that requires effective treatment. In the treatment of depression, traditional Chinese medicine (TCM) offers obvious advantages, fewer adverse reactions, and a lower recurrence rate. AIMTo evaluate the clinical benefits of Guipi decoction combined with escitalopram oxalate tablets for individuals with depression. METHODSIn total, 80 patients diagnosed as having depression were enrolled in the study and divided into either an experimental group or a control group. All of the patients were orally administered escitalopram oxalate tablets. Additionally, the experimental group received Jiajian Guipi decoction and reduced Governor vessel fumigation over 4 wk. TCM syndrome scores, Hamilton depression rating scale (HAM-D) scores, self-rating depression scale (SDS) scores, and Pittsburgh sleep quality index scores were measured for the two groups and compared before and after the treatment. The two groups were monitored for any adverse reactions. RESULTSAfter 4 wk of treatment, both groups exhibited a significant reduction in TCM syndrome scores compared with their pre-treatment scores (P < 0.05). However, the experimental group exhibited significantly lower TCM syndrome scores than the control group (P < 0.05). Similarly, the post-treatment SDS and HAM-D-24 scores were significantly lower in both groups than the pre-treatment scores (P < 0.05), with the experimental group exhibiting lower scores than the control group (P < 0.05). The total treatment efficiency was significantly better in the experimental group (97.14%) than in the control group (77.78%) (P < 0.05). Furthermore, after 4 wk of treatment, the Pittsburgh sleep quality index scores for both groups were significantly lower than those before the treatment (P < 0.05), with the experimental group exhibiting lower scores than the control group (P < 0.05). The incidence of adverse reactions was significantly lower in the experimental group than in the control group (P < 0.05). CONCLUSIONThe combination of Guipi decoction and escitalopram oxalate tablets was found to be an effective and safe treatment for depression. This combination could reduce TCM syndrome scores, improve depressive symptoms, and enhance sleep quality.
引用
收藏
页码:7017 / 7025
页数:9
相关论文
共 50 条
  • [41] Efficacy and safety of Shugan Jieyu Decoction in the treatment of coronary heart disease complicated with depression
    Li, Zhenzhen
    Zhang, Jianying
    Qiao, Mingqi
    Wang, Xiaojin
    Guo, Yinghui
    Wang, Haijun
    MEDICINE, 2023, 102 (11) : E33176
  • [42] Safety and Preliminary Efficacy Evaluation of SAM-e and Escitalopram in the Treatment of Depression Associated with PD
    Varanese, Sara
    Hamid, Hamada
    Hirsh, Scott
    Howard, Jonathan
    Brown, Richard
    Bottiglieri, Teodoro
    Morrison, Chris
    Moshier, Erin
    Godbold, James
    Di Rocco, Alessandro
    NEUROLOGY, 2011, 76 (09) : A541 - A541
  • [43] Analysis of the Efficacy and Safety of Benzbromarone Combined with Sodium Bicarbonate Tablets in the Treatment of Hyperuricemia
    Zhu, Wei-Hong
    Huang, Ke-Ke
    Zhang, Xin-Yi
    Deng, Bao-Zhu
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (11)
  • [44] Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis
    Prouse, PJ
    Bevis, PJ
    Bluhmki, E
    Distel, M
    CLINICAL THERAPEUTICS, 1996, 18 (03) : 429 - 439
  • [45] CLINICAL STUDY ON THE EFFICACY AND TOLERABILITY OF ESCITALOPRAM IN PATIENTS DIAGNOSED WITH SOCIAL ANXIETY
    Ionescu, D.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [46] Study on the clinical efficacy and safety of baloxavir marboxil tablets in the treatment of influenza A
    Qiu, Chaochao
    Cheng, Fang
    Ye, Xinchun
    Wu, Zhengxing
    Ning, Hongye
    Liu, Saiduo
    Wu, Lianpeng
    Zhang, Yiyang
    Shi, Jichan
    Jiang, Xiangao
    FRONTIERS IN MEDICINE, 2024, 11
  • [47] Efficacy and safety of duloxetine in patients with melancholic depression
    Tudor, C.
    Cantemir, A.
    Grigorescu, G.
    Vasiliu, O.
    Vasile, D.
    Zavoianu, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S388 - S388
  • [48] Combined Effects of Paroxetine and Acupuncture on Clinical Efficacy and Cognitive Function of Senile Depression Patients
    Wang, Zhen
    Jia, Xiaofei
    Lin, Zhang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (04): : 802 - 807
  • [49] Exercise for Depression: Efficacy, Safety and Clinical Trial Implications
    Dunlop, Boadie W.
    Self, Rachel L.
    PSYCHOPHARMACOLOGY BULLETIN, 2008, 41 (04) : 65 - 75
  • [50] Clinical efficacy and safety of the Shugan Jieyu capsule in patients with acute myocardial infarction and depression
    Liu, Wei
    Qin, Jun
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2016, 51 (06): : 534 - 543